Related Experiment Videos

Reprograming Carcinoma Associated Fibroblasts by microRNAs

Y Xu1, X Zhou2, M Mei1

  • 1Research Center of Basic Medical Science, Tianjin Medical University, Tianjin 300070. China.

Current Molecular Medicine
|December 7, 2017
PubMed

Insights

Reprogramming carcinoma-associated fibroblasts (CAFs) using microRNAs offers a novel cancer therapy. This approach converts CAFs into normal fibroblasts, potentially improving treatment efficacy and patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Carcinoma-associated fibroblasts (CAFs) are key players in cancer development and serve as therapeutic targets.
  • Current therapies targeting CAFs show limited efficacy due to non-specific biomarkers and potential adverse effects like immunosuppression.
  • Depleting CAFs can paradoxically accelerate cancer progression and reduce survival.

Purpose of the Study:

  • To review microRNAs that can functionally convert CAFs into normal fibroblasts.
  • To explore the role of microRNA-mediated CAF reprogramming in cancer treatment strategies.
  • To highlight the impact of CAFs on tumorigenesis and chemo-resistance.

Main Methods:

  • Literature review focusing on microRNAs targeting CAFs.
  • Analysis of signaling pathways and metabolic mechanisms involved in CAF transformation.
  • Examination of the role of CAFs in cancer progression and drug resistance.

Main Results:

  • Restoring specific microRNA expression can reprogram CAFs into normal fibroblasts.
  • MicroRNA-mediated reprogramming targets key signaling and metabolic pathways within CAFs.
  • This strategy offers an alternative to CAF ablation, potentially avoiding adverse effects.

Conclusions:

  • MicroRNA-based reprogramming of CAFs represents a promising novel strategy for cancer therapy.
  • Targeting microRNAs for CAF conversion may overcome limitations of current CAF-targeting drugs.
  • Understanding microRNA roles in CAF transformation is crucial for developing effective cancer treatments.
Keywords:
Carcinoma-associated fibroblastsmetabolic pathwaymicroRNAreprogrammingsignaling pathwaytarget therapy

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K